GCV Synergize 2017
Skip Content

11 October 2017

Novartis fits the picture as ImaginAb raises $8m

ImaginAb, which has now raised approximately $4m in total, will continue development of the imaging agent it is developing for T-cell tumours.

Author: Sam McCaffrey, Reporter

US-based diagnostic imaging technology developer ImaginAb completed an $8m funding round on Monday featuring Novartis Venture Fund (NVF), the corporate venturing unit formed by pharmaceutical firm Novartis.